Summary

The global TYK2 Targeting Drugs market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
TYK2 target drugs mainly target tyrosine kinase 2 (TYK2), which is a member of the JAK kinase family and plays a key role in inflammatory immune diseases by regulating specific cytokine signal transduction.
In 2025, the North America TYK2 Targeting Drugs market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of TYK2 Targeting Drugs include Bristol Myers Squibb, InnoCare, Takeda (Nimbus Therapeutics), Qiyuan Biotechnology, Inventisbio, Changzhou Hengbang Pharmaceutical, Ventyx Biosciences, Galapagos NV, Oncostellae, BeiGene, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global TYK2 Targeting Drugs market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Bristol Myers Squibb
InnoCare
Takeda (Nimbus Therapeutics)
Qiyuan Biotechnology
Inventisbio
Changzhou Hengbang Pharmaceutical
Ventyx Biosciences
Galapagos NV
Oncostellae
BeiGene
Sareum Holdings Pic
Guangzhou Zaiji Pharmaceutical
Segment by Type
Single-target Inhibitors
Dual-target Inhibitors
Segment by Application
Psoriasis
Systemic Lupus Erythematosus
Dermatitis
Arthritis
Others
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of TYK2 Targeting Drugs sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of TYK2 Targeting Drugs manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, TYK2 Targeting Drugs product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the TYK2 Targeting Drugs value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 TYK2 Targeting Drugs Product Scope
1.2 TYK2 Targeting Drugs by Type
1.2.1 Global TYK2 Targeting Drugs Sales by Type (2021, 2025 & 2032)
1.2.2 Single-target Inhibitors
1.2.3 Dual-target Inhibitors
1.3 TYK2 Targeting Drugs by Application
1.3.1 Global TYK2 Targeting Drugs Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Psoriasis
1.3.3 Systemic Lupus Erythematosus
1.3.4 Dermatitis
1.3.5 Arthritis
1.3.6 Others
1.4 Global TYK2 Targeting Drugs Market Estimates and Forecasts (2021-2032)
1.4.1 Global TYK2 Targeting Drugs Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global TYK2 Targeting Drugs Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global TYK2 Targeting Drugs Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global TYK2 Targeting Drugs Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global TYK2 Targeting Drugs Historical Market Scenario by Region (2021-2026)
2.2.1 Global TYK2 Targeting Drugs Sales Market Share by Region (2021-2026)
2.2.2 Global TYK2 Targeting Drugs Revenue Market Share by Region (2021-2026)
2.3 Global TYK2 Targeting Drugs Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global TYK2 Targeting Drugs Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global TYK2 Targeting Drugs Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America TYK2 Targeting Drugs Market Size and Prospects (2021-2032)
2.4.2 Europe TYK2 Targeting Drugs Market Size and Prospects (2021-2032)
2.4.3 China TYK2 Targeting Drugs Market Size and Prospects (2021-2032)
2.4.4 Japan TYK2 Targeting Drugs Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global TYK2 Targeting Drugs Historical Market Review by Type (2021-2026)
3.1.1 Global TYK2 Targeting Drugs Sales by Type (2021-2026)
3.1.2 Global TYK2 Targeting Drugs Revenue by Type (2021-2026)
3.1.3 Global TYK2 Targeting Drugs Average Price by Type (2021-2026)
3.2 Global TYK2 Targeting Drugs Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global TYK2 Targeting Drugs Sales Forecast by Type (2027-2032)
3.2.2 Global TYK2 Targeting Drugs Revenue Forecast by Type (2027-2032)
3.2.3 Global TYK2 Targeting Drugs Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of TYK2 Targeting Drugs
4 Global Market Size by Application
4.1 Global TYK2 Targeting Drugs Historical Market Review by Application (2021-2026)
4.1.1 Global TYK2 Targeting Drugs Sales by Application (2021-2026)
4.1.2 Global TYK2 Targeting Drugs Revenue by Application (2021-2026)
4.1.3 Global TYK2 Targeting Drugs Average Price by Application (2021-2026)
4.2 Global TYK2 Targeting Drugs Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global TYK2 Targeting Drugs Sales Forecast by Application (2027-2032)
4.2.2 Global TYK2 Targeting Drugs Revenue Forecast by Application (2027-2032)
4.2.3 Global TYK2 Targeting Drugs Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in TYK2 Targeting Drugs Applications
5 Competition Landscape by Players
5.1 Global TYK2 Targeting Drugs Sales by Player (2021-2026)
5.2 Global Top TYK2 Targeting Drugs Players by Revenue (2021-2026)
5.3 Global TYK2 Targeting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on TYK2 Targeting Drugs revenue as of 2025
5.4 Global TYK2 Targeting Drugs Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of TYK2 Targeting Drugs, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of TYK2 Targeting Drugs, Product Type & Application
5.7 Global Key Manufacturers of TYK2 Targeting Drugs, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America TYK2 Targeting Drugs Sales by Company
6.1.1.1 North America TYK2 Targeting Drugs Sales by Company (2021-2026)
6.1.1.2 North America TYK2 Targeting Drugs Revenue by Company (2021-2026)
6.1.2 North America TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
6.1.3 North America TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
6.1.4 North America TYK2 Targeting Drugs Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe TYK2 Targeting Drugs Sales by Company
6.2.1.1 Europe TYK2 Targeting Drugs Sales by Company (2021-2026)
6.2.1.2 Europe TYK2 Targeting Drugs Revenue by Company (2021-2026)
6.2.2 Europe TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
6.2.3 Europe TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
6.2.4 Europe TYK2 Targeting Drugs Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China TYK2 Targeting Drugs Sales by Company
6.3.1.1 China TYK2 Targeting Drugs Sales by Company (2021-2026)
6.3.1.2 China TYK2 Targeting Drugs Revenue by Company (2021-2026)
6.3.2 China TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
6.3.3 China TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
6.3.4 China TYK2 Targeting Drugs Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan TYK2 Targeting Drugs Sales by Company
6.4.1.1 Japan TYK2 Targeting Drugs Sales by Company (2021-2026)
6.4.1.2 Japan TYK2 Targeting Drugs Revenue by Company (2021-2026)
6.4.2 Japan TYK2 Targeting Drugs Sales Breakdown by Type (2021-2026)
6.4.3 Japan TYK2 Targeting Drugs Sales Breakdown by Application (2021-2026)
6.4.4 Japan TYK2 Targeting Drugs Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Information
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Bristol Myers Squibb TYK2 Targeting Drugs Products Offered
7.1.5 Bristol Myers Squibb Recent Development
7.2 InnoCare
7.2.1 InnoCare Company Information
7.2.2 InnoCare Business Overview
7.2.3 InnoCare TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.2.4 InnoCare TYK2 Targeting Drugs Products Offered
7.2.5 InnoCare Recent Development
7.3 Takeda (Nimbus Therapeutics)
7.3.1 Takeda (Nimbus Therapeutics) Company Information
7.3.2 Takeda (Nimbus Therapeutics) Business Overview
7.3.3 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Products Offered
7.3.5 Takeda (Nimbus Therapeutics) Recent Development
7.4 Qiyuan Biotechnology
7.4.1 Qiyuan Biotechnology Company Information
7.4.2 Qiyuan Biotechnology Business Overview
7.4.3 Qiyuan Biotechnology TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Qiyuan Biotechnology TYK2 Targeting Drugs Products Offered
7.4.5 Qiyuan Biotechnology Recent Development
7.5 Inventisbio
7.5.1 Inventisbio Company Information
7.5.2 Inventisbio Business Overview
7.5.3 Inventisbio TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Inventisbio TYK2 Targeting Drugs Products Offered
7.5.5 Inventisbio Recent Development
7.6 Changzhou Hengbang Pharmaceutical
7.6.1 Changzhou Hengbang Pharmaceutical Company Information
7.6.2 Changzhou Hengbang Pharmaceutical Business Overview
7.6.3 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Products Offered
7.6.5 Changzhou Hengbang Pharmaceutical Recent Development
7.7 Ventyx Biosciences
7.7.1 Ventyx Biosciences Company Information
7.7.2 Ventyx Biosciences Business Overview
7.7.3 Ventyx Biosciences TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Ventyx Biosciences TYK2 Targeting Drugs Products Offered
7.7.5 Ventyx Biosciences Recent Development
7.8 Galapagos NV
7.8.1 Galapagos NV Company Information
7.8.2 Galapagos NV Business Overview
7.8.3 Galapagos NV TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Galapagos NV TYK2 Targeting Drugs Products Offered
7.8.5 Galapagos NV Recent Development
7.9 Oncostellae
7.9.1 Oncostellae Company Information
7.9.2 Oncostellae Business Overview
7.9.3 Oncostellae TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Oncostellae TYK2 Targeting Drugs Products Offered
7.9.5 Oncostellae Recent Development
7.10 BeiGene
7.10.1 BeiGene Company Information
7.10.2 BeiGene Business Overview
7.10.3 BeiGene TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.10.4 BeiGene TYK2 Targeting Drugs Products Offered
7.10.5 BeiGene Recent Development
7.11 Sareum Holdings Pic
7.11.1 Sareum Holdings Pic Company Information
7.11.2 Sareum Holdings Pic Business Overview
7.11.3 Sareum Holdings Pic TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Sareum Holdings Pic TYK2 Targeting Drugs Products Offered
7.11.5 Sareum Holdings Pic Recent Development
7.12 Guangzhou Zaiji Pharmaceutical
7.12.1 Guangzhou Zaiji Pharmaceutical Company Information
7.12.2 Guangzhou Zaiji Pharmaceutical Business Overview
7.12.3 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Products Offered
7.12.5 Guangzhou Zaiji Pharmaceutical Recent Development
8 TYK2 Targeting Drugs Manufacturing Cost Analysis
8.1 TYK2 Targeting Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of TYK2 Targeting Drugs
8.4 TYK2 Targeting Drugs Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 TYK2 Targeting Drugs Distributors List
9.3 TYK2 Targeting Drugs Customers
10 TYK2 Targeting Drugs Market Dynamics
10.1 TYK2 Targeting Drugs Industry Trends
10.2 TYK2 Targeting Drugs Market Drivers
10.3 TYK2 Targeting Drugs Market Challenges
10.4 TYK2 Targeting Drugs Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer